Cytosorbents (CTSO) Other Non Operating Income (2015 - 2026)
Cytosorbents' (CTSO) quarterly Other Non Operating Income came in at -$1.2 million in Q1 2026, down 140.74% YoY from $3.0 million in Q1 2025, and down 736.27% on a QoQ basis from $193000.0 in Q4 2025.
Cytosorbents (CTSO) Other Non Operating Income (2015 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 12 years of Other Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Other Non Operating Income fell 140.74% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 2262.33% YoY) and the FY2025 annual result came in at $9.3 million, up 320.62% from the prior year.
- Other Non Operating Income retreated to -$1.2 million in Q1 2026, from $193000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $6.2 million in Q2 2025 to a low of -$4.9 million in Q4 2024.
- A 5-year average of $198175.6 and a median of -$64000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 1177.6% — and 2025, when it soared 1235.66%.
- Tracing CTSO's Other Non Operating Income over 5 years: stood at $4.5 million in 2022, then slumped by 40.61% to $2.7 million in 2023, then slumped by 282.8% to -$4.9 million in 2024, then soared by 103.93% to $193000.0 in 2025, then tumbled by 736.27% to -$1.2 million in 2026.
- The last three Other Non Operating Income figures came in at -$1.2 million (Q1 2026), $193000.0 (Q4 2025), and -$64000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -911,000.00 |
| Mar 31, 2026 | -1.23 Mn |
| Dec 31, 2025 | 193,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | 6.18 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | -4.91 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | -544,000.00 |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | -1.81 Mn |
| Jun 30, 2023 | 414,974.00 |
| Mar 31, 2023 | 660,681.00 |
| Dec 31, 2022 | 4.52 Mn |
| Sep 30, 2022 | -3.23 Mn |
| Jun 30, 2022 | -2.52 Mn |
| Mar 31, 2022 | -1.21 Mn |
| Dec 31, 2021 | -493,488.00 |
| Sep 30, 2021 | -1.01 Mn |